Acción EUCR EUCRATES BIOMEDICAL ACQUISITION CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Eucrates Biomedical Acquisition Corp.

Acciones

EUCR

VGG3141W1068

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) dropped from NASDAQ Composite Index
EUCRATES BIOMEDICAL ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt
Eucrates Biomedical Acquisition to Dissolve, Liquidate
Eucrates Biomedical Acquisition : Announces Liquidation - Form 8-K
EUCRATES BIOMEDICAL ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Eucrates Biomedical Acquisition Corp. Announces Liquidation
Eucrates Biomedical Acquisition : New Financial Obligation - Form 8-K
EUCRATES BIOMEDICAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
EUCRATES BIOMEDICAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Eucrates Biomedical Acquisition Corp. announced that it has received $0.096 million in funding from Eucrates Llc
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
EUCRATES BIOMEDICAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
Eucrates Biomedical Acquisition Corp. announced that it has received $0.6 million in funding from Eucrates Llc
EUCRATES BIOMEDICAL ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure (form 8-K)
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción EUCR
  4. Noticias Eucrates Biomedical Acquisition Corp.
  5. Otros idiomas